Journal
/
Medicina
/
An Efficient Modified Method for Treating Wasting Marmoset Syndrome
/
Combined Oral, Subcutaneous, and Intravenous Administration of Therapeutic Agents to Marmoset for Treating Wasting Marmoset Syndrome (WMS)
JoVE Journal
Medicina
This content is Free Access.
JoVE Journal Medicina
Combined Oral, Subcutaneous, and Intravenous Administration of Therapeutic Agents to Marmoset for Treating Wasting Marmoset Syndrome (WMS)

Combined Oral, Subcutaneous, and Intravenous Administration of Therapeutic Agents to Marmoset for Treating Wasting Marmoset Syndrome (WMS)

26 Views

•

01:50 min

•

July 12, 2024

DOI:

10.3791/201991-v

DOI:
10.3791/201991-v

•

01:50 min
July 12, 2024

•

0 Views
, , ,
1Support Unit for Animal Resources Development, Research Resources Division,RIKEN Center for Brain Science

Explore More Videos

Wasting Marmoset SyndromeWMSCommon MarmosetCallithrix JacchusTranexamic AcidSupportive MeasuresAmino Acid FormulationRinger’s LactateVitamin FormulationIron FormulationIntravenous AdministrationSubcutaneous AdministrationOral AdministrationTreatment Modification

Read Article

Cite this Article

Combined Oral, Subcutaneous, and Intravenous Administration of Therapeutic Agents to Marmoset for Treating Wasting Marmoset Syndrome (WMS). J. Vis. Exp. (Pending Publication), e201991, doi:10.3791/201991 (2024).

Download .ris file

Copy

Share Video

.

Copy